ACADIA Pharmaceuticals Inc. Stock Price (ACAD)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

Inovio Pharmaceuticals price target cut to $25 from $36 at Benchmark, stock rated buyTue, 29 Sep 2020 10:43:54 UTC via MarketWatch
Pieris Pharmaceuticals (PIRS) Presents at ESMO Virtual Congress - SlideshowFri, 25 Sep 2020 13:50:22 UTC via Seeking Alpha
Zynerba Pharmaceuticals - Whether They've Cracked The Code For Fully Methylated FX Syndrome PatientsThu, 24 Sep 2020 14:52:01 UTC via Seeking Alpha
Ayala Pharmaceuticals (AYLA) - Updated ACCURACY Phase 2 Data Review PresentationWed, 23 Sep 2020 06:47:44 UTC via Seeking Alpha
Does BioCryst Pharmaceuticals (NASDAQ:BCRX) Have A Healthy Balance Sheet?Tue, 22 Sep 2020 07:25:33 UTC via Yahoo Finance
Ayala Pharmaceuticals Inc (AYLA) Investor Presentation - SlideshowTue, 22 Sep 2020 06:59:06 UTC via Seeking Alpha
Zentalis Pharmaceuticals (ZNTL) Investor Presentation - SlideshowMon, 21 Sep 2020 17:12:19 UTC via Seeking Alpha
PMV Pharmaceuticals Seeks $125 Million To Enter TrialsMon, 21 Sep 2020 17:00:36 UTC via Seeking Alpha
Reata Pharmaceuticals Can RallyMon, 21 Sep 2020 16:01:16 UTC via Seeking Alpha
PMV Pharmaceuticals sets IPO terms, to raise $132.3 mlnMon, 21 Sep 2020 06:50:03 UTC via MarketWatch

ACADIA Pharmaceuticals Inc. Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:ACAD

You don't have any alerts set for IEX:ACAD.

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. The firms product include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

CEOStephen R. Davis IndustryBiotechnology SectorHealth Technology Websitehttp://www.acadia-pharm.com Issue ExchangeNASDAQ Issue TypeUnknown

Real-time ACAD to USD Trade Analysis on IEX

Market Status Open

Time Elapsed

Trades Analyzed

Last Price

Trades per Minute

Volume per Trade Average

Volume per Minute Average

Largest Trade Volume

Largest Trade Cost

Total Volume

Total Buy Volume

Total Sell Volume

Buy to Sell Volume

Buy to Sell Trades

USD per Trade Average

USD per Minute Average

USD Total Volume

Buy/Sell stats are based on the side that filled the order.

Real-time Trade History

Waiting for IEX trades to start ...

The last recorded trade was over an hour ago.